report-image

Mice Model Market Analysis By Type, Application, Region And Segments Forecast By 2033

  • PUBLISHED ON
  • 2024-03-07
  • NO OF PAGES
  • 300
  • CATEGORY
  • Healthcare & Life Sciences

Market Overview

The global mice model market size was valued at USD 1.4 billion in 2022 and is projected to reach USD 2.9 billion by 2033, growing at a CAGR of 13.9 % during the forecast period.

 

Report Scope

Report Attributes

Description

Market Forecast in 2022

USD 1.4 billion

Market Forecast in 2033

USD 2.7 billion

CAGR % 2023-2033

13.9%

Base Year

2022

Historic Data

2020-2021

Forecast Period

2023-2033

Report USP

Product, end-user industry, company share, company heat map, company Capacity Technology Product capacity, growth factors and more

Key Companies

Applied StemCell, Inc.; Aragen Life Sciences Ltd.; Biocytogen Boston Corporation; Charles River Laboratories International, Inc.; CompareNetworks, Inc.; Creative Biolabs.; Crown Bioscience by JSR Life Sciences, LLC; Cyagen US Inc. by PolyGene AG; Envigo by Inotiv, Inc.; GenOway; Harbour BioMed; Others

 

 

 Mice Model Market: Description

The global mice model market refers to the market for laboratory mice that are used as model organisms in scientific research and drug discovery. Mice models are widely used in various fields, including genetics, immunology, oncology, neurology, and toxicology, among others, to study human diseases and develop potential treatments.

Mice models are preferred in research due to their genetic similarity to humans, short reproductive cycle, small size, and ease of handling and maintenance in laboratory settings. They play a crucial role in understanding the underlying mechanisms of diseases, testing new drugs and therapies, and evaluating their efficacy and safety before human trials.

The mice model market encompasses the production, distribution, and usage of mice models in research institutions, pharmaceutical and biotechnology companies, contract research organizations, and academic laboratories worldwide. These mice models are typically genetically modified or selectively bred to mimic specific human diseases or conditions, such as cancer, diabetes, Alzheimer's disease, and cardiovascular disorders.

The market is driven by the increasing demand for personalized medicine, growing prevalence of chronic diseases, advancements in genetic engineering technologies, and rising investments in biomedical research. Additionally, the need for more accurate and reliable animal models to reduce the attrition rate in drug development further fuels the market growth.

Mice share a significant portion of their genetic makeup with humans, making them excellent models for studying human diseases and conditions. This similarity allows researchers to investigate the molecular and genetic basis of various diseases and develop effective therapies.

 Mice Model Market: Key Trends

·         Rising Demand For Personalized Medicine:

With the increasing focus on personalized medicine, there is a growing demand for mice models that closely mimic human genetics and diseases. Researchers are developing genetically modified mice models that carry specific mutations or genetic variations found in patient populations. These models enable the study of individualized treatment responses and facilitate the development of targeted therapies.

·         Expansion of Humanized Mice Models:

Humanized mice models, where human cells, tissues, or immune systems are engrafted into mice, are gaining popularity. These models allow researchers to study human-specific diseases, immune responses, and evaluate the efficacy of human-specific therapeutics. The development of humanized mice models is driven by the need to bridge the gap between preclinical research and clinical trials.

Mice Model Market: Segmental Analysis

By Technology

·         CRISPR/CAS9

·         Embryonic Stem Cell Injection

·         Nuclear Transfer

·         Other Technologies

By Mode

·         Outsourced

·         In-house

By Application

·         Oncology Studies

·         Cardiovascular Studies

·         Genetic Studies

·         Endocrine Metabolic Studies

·         Neurological Studies

·         Immunology & Inflammation studies

·         Other

Mice Model Market: Geographical Landscape

North America holds a prominent position in the mice model market. The United States, in particular, is a major contributor, driven by its robust biomedical research infrastructure, well-established regulatory framework, and presence of leading pharmaceutical and biotechnology companies.

Canada also has a notable presence in the market, with several research institutions and companies actively utilizing mice models for scientific research. Europe is another key region in the mice model market.

Countries such as the United Kingdom, Germany, France, and the Netherlands have well-developed research infrastructure and a strong focus on biomedical research. These countries host renowned academic institutions, contract research organizations (CROs), and biopharmaceutical companies that extensively use mice models for various research applications.

The Asia Pacific region has been experiencing significant growth in the mice model market. Countries like China, Japan, and South Korea have made substantial investments in biomedical research, resulting in the expansion of research capabilities and increased utilization of mice models.

Additionally, emerging economies such as India and Singapore are actively fostering research collaborations and attracting international research organizations and companies to establish their presence in the region.

Although the mice model market in the Middle East and Africa is relatively smaller compared to other regions, there is a growing interest in biomedical research and the use of mice models. Countries like Israel, Saudi Arabia, and South Africa have research institutions and initiatives dedicated to advancing scientific knowledge and promoting the use of animal models in research.

 Mice Model Market: Impact of COVID

The pandemic caused disruptions in global supply chains, including the production and distribution of mice models. Restrictions on transportation, lockdown measures, and reduced workforce in breeding facilities and research institutions led to delays and shortages in the supply of mice models. This affected research activities that heavily rely on the availability of specific mouse strains. COVID-19 pandemic prompted a shift in research priorities towards studying the virus and developing treatments and vaccines.

Many research institutions and companies redirected their resources and efforts towards COVID-19-related research, temporarily reducing the demand for mice models in other areas of study. However, there has also been an increased demand for mice models specifically for COVID-19 research and vaccine development.

The closure of research institutions, universities, and non-essential laboratories during the pandemic resulted in the temporary suspension or reduction of non-COVID-19 research activities.

This pause in research projects affected the demand for mice models, as studies were delayed or put on hold until the resumption of normal research operations. The urgent need for COVID-19 vaccines led to an unprecedented pace of vaccine development. Mice models, particularly genetically modified mice, played a crucial role in preclinical testing of vaccine candidates.

The mice model market witnessed an increased demand for strains suitable for COVID-19 research, such as transgenic mice expressing human ACE2 receptors.

The COVID-19 pandemic highlighted the importance of in vivo studies to understand disease mechanisms and evaluate potential therapeutics. Mice models, as a key tool for in vivo research, gained even more significance during the pandemic.

This emphasis on in vivo studies may lead to a sustained demand for mice models beyond COVID-19 research, as researchers recognize the value of studying diseases and developing treatments in living organisms.

 Mice Model Market: Key Companies

·         Applied StemCell, Inc.

·         Aragen Life Sciences Ltd.

·         Biocytogen Boston Corporation

·         Charles River Laboratories International, Inc.

·         CompareNetworks, Inc.

·         Creative Biolabs.

·         Crown Bioscience by JSR Life Sciences, LLC

·         Cyagen US Inc. by PolyGene AG

·         Envigo by Inotiv, Inc.

·         GenOway

·         Harbour BioMed

Mice Model Market: Regional Scope

North America

·         U.S

·         Canada

·         Mexico

Europe

·         U.K

·         Germany

·         France

·         Italy

·         Spain

·         Rest of Europe

Asia Pacific

·         Chain

·         India

·         Japan

·         South Korea

·         Australia

·         Rest of Asia pacific

South America

·         Brazil

·         Argentina

·         Rest of south America

Middle East and Africa

·         Saudi Arabia

·         UAE

·         Egypt

·         South Africa

·         Rest of Middle East and Africa

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size and growth projections?

The global mice model market size was valued at USD 1.4 billion in 2022 and is projected to reach USD 2.9 billion by 2033, growing at a CAGR of 13.9 % during the forecast period.

What are the trends shaping various markets?

With the increasing focus on personalized medicine, there is a growing demand for mice models that closely mimic human genetics and diseases.

Who are the key competitors of market Players?

Some of the major players operating within the market are Applied StemCell, Inc.; Aragen Life Sciences Ltd.; Biocytogen Boston Corporation; Charles River Laboratories International, Inc.; CompareNetworks, Inc.; Creative Biolabs.; Crown Bioscience by JSR Life Sciences, LLC; Cyagen US Inc. by PolyGene AG; Envigo by Inotiv, Inc.; GenOway; Harbour BioMed; Others

What are the top performing segments, and countries / regions of each of the markets?

North America holds a prominent position in the mice model market. The United States, in particular, is a major contributor, driven by its robust biomedical research infrastructure, well-established regulatory framework, and presence of leading pharmaceutical and biotechnology companies.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $4750

Only Four Thousand Seven Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $5750

Only Five Thousand Seven Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $6750

Only Six Thousand Seven Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI